S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83

Compare Stocks

Date Range: 

 Rayonier Advanced MaterialsAmerican VanguardWallbridge MiningNomad RoyaltyZomedica
SymbolNYSE:RYAMNYSE:AVDTSE:WMTSE:NSRNYSEAMERICAN:ZOM
Price Information
Current Price$5.84$15.08C$0.40C$9.45$0.37
50-Day Moving Average$6.83$15.65C$0.52C$8.92$0.00
52-Week Low$5.31$14.16C$0.37C$7.34$0.15
52-Week High$11.30$22.49C$0.86C$12.10$2.91
MarketRank™
Overall Score2.22.91.91.71.3
Analysis Score3.53.53.53.20.0
Community Score4.04.04.53.54.7
Dividend Score0.01.70.01.70.0
Ownership Score1.73.31.70.01.7
Earnings & Valuation Score1.91.90.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldN/A
Consensus Price Target$10.00$23.50C$1.00C$12.25N/A
% Upside from Price Target71.23% upside55.84% upside153.16% upside29.63% upsideN/A
Trade Information
Market Cap$372.22 million$466.49 millionC$322.90 millionC$535.41 million$365.50 million
Beta3.540.81N/AN/A0.52
Average Volume486,534137,525721,87525,86970,273,797
Sales & Book Value
Annual Revenue$1.74 billion$458.70 millionN/AC$27.15 millionN/A
Price / Sales0.211.02N/A19.72N/A
Cashflow$2.36 per share$1.34 per shareC$0.07 per shareC$0.42 per shareN/A
Price / Cash2.4711.236.0622.37N/A
Book Value$12.32 per share$11.91 per shareC$0.40 per shareC$4.77 per share$0.28 per share
Price / Book0.471.27N/A1.98N/A
Profitability
Net Income$560 thousand$15.24 millionN/AN/A$-16.91 million
EPS$1.53$0.71C($0.02)C$0.22($0.06)
Trailing P/E Ratio3.8221.24N/A42.38N/A
Forward P/E RatioN/A16.94
P/E Growth2.26N/AN/AN/AN/A
Net Margins5.86%4.01%N/AN/AN/A
Return on Equity (ROE)-4.65%5.93%N/AN/A-8.80%
Return on Assets (ROA)-1.34%3.02%N/AN/A-8.52%
Dividend
Annual PayoutN/A$0.08C$1.86C$0.16N/A
Dividend YieldN/A0.53%470.89%1.68%N/A
Three-Year Dividend GrowthN/A-33.33%N/AN/AN/A
Payout RatioN/A11.27%N/A 71.01%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.180.370.0420.25N/A
Current Ratio2.582.114.962.2856.39
Quick Ratio1.921.174.962.0456.10
Ownership Information
Institutional Ownership Percentage72.60%79.33%N/AN/A13.36%
Insider Ownership Percentage3.82%5.70%N/AN/A1.99%
Miscellaneous
Employees4,00077148,250619
Shares Outstanding63.74 million30.93 million817.46 million56.66 million979.90 million
Next Earnings Date2/23/2022 (Estimated)3/10/2022 (Estimated)3/18/2022 (Estimated)2/17/2022 (Estimated)2/24/2022 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableNot Optionable
SourceHeadline
Zomedica Corp (ZOM) Stock Loses -19.05% This Week; Should You Buy? - InvestorsObserverZomedica Corp (ZOM) Stock Loses -19.05% This Week; Should You Buy? - InvestorsObserver
investorsobserver.com - December 6 at 11:42 PM
Fetch dvm360®: Saturdays featured sessions - DVM 360Fetch dvm360®: Saturday's featured sessions - DVM 360
dvm360.com - December 4 at 7:07 AM
Analysts Predict Zomedica Corp. (AMEX:ZOM) To Reach $1.20 In 12 MonthsAnalysts Predict Zomedica Corp. (AMEX:ZOM) To Reach $1.20 In 12 Months
marketingsentinel.com - December 3 at 2:11 PM
Zomedica Stock Looks Tempting Here, But There’s Likely More DownsideZomedica Stock Looks Tempting Here, But There’s Likely More Downside
investorplace.com - December 3 at 7:03 AM
Weak Fundamental Momentum Pushes Zomedica Corp. (ZOM) LowerWeak Fundamental Momentum Pushes Zomedica Corp. (ZOM) Lower
marketingsentinel.com - November 30 at 1:37 PM
Is Zomedica Corp. (AMEX: ZOM) A Good Investment For New Investors Now?Is Zomedica Corp. (AMEX: ZOM) A Good Investment For New Investors Now?
stocksregister.com - November 26 at 12:24 PM
Zomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers Acquires 250,000 SharesZomedica Corp. (NYSEAMERICAN:ZOM) Director Johnny D. Powers Acquires 250,000 Shares
americanbankingnews.com - November 22 at 11:20 PM
Should You Sell Zomedica Corp (ZOM) Stock Monday? - InvestorsObserverShould You Sell Zomedica Corp (ZOM) Stock Monday? - InvestorsObserver
investorsobserver.com - November 22 at 6:14 PM
Market cap of Zomedica Corp. [ZOM] reaches 450.80M – now what?Market cap of Zomedica Corp. [ZOM] reaches 450.80M – now what?
dbtnews.com - November 22 at 5:36 PM
Antibiotics in Aquaculture Market Report | Valuates Reports With Fengchen Group Co.,Ltd, Bayer AG, Merck KGaA, - openPRAntibiotics in Aquaculture Market Report | Valuates Reports With Fengchen Group Co.,Ltd, Bayer AG, Merck KGaA, - openPR
openpr.com - November 19 at 6:43 AM
Why Zomedica Stock Is Sinking This Week - Motley FoolWhy Zomedica Stock Is Sinking This Week - Motley Fool
fool.com - November 18 at 5:47 PM
Feed antibiotics Market To Get Catalyzed With Technological Advancements 2027 || – LSMedia - LSMediaFeed antibiotics Market To Get Catalyzed With Technological Advancements 2027 || – LSMedia - LSMedia
liverpoolstudentmedia.com - November 18 at 12:43 PM
Zomedica Is Languishing Today, but Keep an Eye on This Risky Play - Investorplace.comZomedica Is Languishing Today, but Keep an Eye on This Risky Play - Investorplace.com
investorplace.com - November 18 at 1:20 AM
Zomedica Is Languishing Today, but Keep an Eye on This Risky PlayZomedica Is Languishing Today, but Keep an Eye on This Risky Play
investorplace.com - November 17 at 5:09 PM
Feed Antibiotics Market Size, Growth (2021-2028) | Top Companies – Bayer, Merck, Zomedica, Elanco, Sanofi, Lg Chem, Luitpold Pharmaceuticals, , – Energy Siren - Energy SirenFeed Antibiotics Market Size, Growth (2021-2028) | Top Companies – Bayer, Merck, Zomedica, Elanco, Sanofi, Lg Chem, Luitpold Pharmaceuticals, , – Energy Siren - Energy Siren
energysiren.co.ke - November 17 at 5:17 AM
Is Zomedica Corp (ZOM) Stock a Good Value Monday? - InvestorsObserverIs Zomedica Corp (ZOM) Stock a Good Value Monday? - InvestorsObserver
investorsobserver.com - November 15 at 5:41 PM
Zomedica (NYSEAMERICAN:ZOM) Shares Gap Down to $0.54Zomedica (NYSEAMERICAN:ZOM) Shares Gap Down to $0.54
americanbankingnews.com - November 15 at 1:05 PM
Thinking about buying stock in Creative Realities, Zomedica, Paysafe, Genius Brands, or Canopy Growth Corp? - PRNewswireThinking about buying stock in Creative Realities, Zomedica, Paysafe, Genius Brands, or Canopy Growth Corp? - PRNewswire
prnewswire.com - November 15 at 12:41 PM
ZOMEDICA CORP. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q) - marketscreener.comZOMEDICA CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q) - marketscreener.com
marketscreener.com - November 12 at 6:08 PM
Zomedica posts widening Q3 net loss as SG&A expenses more than doubles - Seeking AlphaZomedica posts widening Q3 net loss as SG&A expenses more than doubles - Seeking Alpha
seekingalpha.com - November 12 at 6:08 PM
Zomedica Announces Third Quarter 2021 Financial Results - Yahoo FinanceZomedica Announces Third Quarter 2021 Financial Results - Yahoo Finance
finance.yahoo.com - November 12 at 6:08 PM
Zomedica Announces Third Quarter 2021 Financial ResultsZomedica Announces Third Quarter 2021 Financial Results
finance.yahoo.com - November 12 at 6:08 PM
MSCI adds ZOM, CLOV, 110 others to US Micro Cap Index, MNKD, SAVA to be deleted - Seeking AlphaMSCI adds ZOM, CLOV, 110 others to US Micro Cap Index, MNKD, SAVA to be deleted - Seeking Alpha
seekingalpha.com - November 12 at 3:06 PM
Feed Antibiotics Market Size and Outlook 2028 | Top Companies - Bayer, Merck, Zomedica, Elanco, Sanofi, Lg Chem, Luitpold Pharmaceuticals, , - Energy SirenFeed Antibiotics Market Size and Outlook 2028 | Top Companies - Bayer, Merck, Zomedica, Elanco, Sanofi, Lg Chem, Luitpold Pharmaceuticals, , - Energy Siren
energysiren.co.ke - November 11 at 3:04 PM
Global Medical Cotton Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: Medline Industries, Dynarex, Johnson & Johnson, Becton Dickinson, 3M, Cardinal Health, Shield L... - Energy SirenGlobal Medical Cotton Market 2021 Future Set to Massive Growth with High CAGR value | Market Players: Medline Industries, Dynarex, Johnson & Johnson, Becton Dickinson, 3M, Cardinal Health, Shield L... - Energy Siren
energysiren.co.ke - November 10 at 11:13 PM
DateCompanyBrokerageAction
11/24/2021American VanguardRoth Capital
Reiterated Rating
11/24/2021Nomad RoyaltyCanaccord Genuity
Lower Price Target
11/24/2021Nomad RoyaltyCIBC
Boost Price Target
11/12/2021Wallbridge MiningEight Capital
Lower Price Target
11/1/2021Nomad RoyaltyRaymond James
Boost Price Target
10/15/2021Nomad RoyaltyCIBC
Reiterated Rating
10/13/2021Nomad RoyaltyRaymond James
Lower Price Target
10/5/2021Nomad RoyaltyScotiabank
Lower Price Target
8/23/2021Nomad RoyaltyCIBC
Lower Price Target
8/20/2021Nomad RoyaltyRaymond James
Reiterated Rating
8/20/2021Nomad RoyaltyScotiabank
Boost Price Target
8/5/2021Rayonier Advanced MaterialsRoyal Bank of Canada
Upgrade
7/30/2021Nomad RoyaltyRaymond James
Lower Price Target
7/29/2021Nomad RoyaltyCIBC
Reiterated Rating
7/16/2021Nomad RoyaltyCanaccord Genuity
Boost Price Target
6/30/2021Nomad RoyaltyCIBC
Reiterated Rating
6/29/2021Nomad RoyaltyRaymond James
Reiterated Rating
6/29/2021Nomad RoyaltyCanaccord Genuity
Boost Price Target
6/3/2021Nomad RoyaltyCanaccord Genuity
Reiterated Rating
5/18/2021Nomad RoyaltyRaymond James
Boost Price Target
5/14/2021Nomad RoyaltyCIBC
Reiterated Rating
5/12/2021Nomad RoyaltyRaymond James
Reiterated Rating
5/11/2021Rayonier Advanced MaterialsRoyal Bank of Canada
Reiterated Rating
5/11/2021Nomad RoyaltyRoyal Bank of Canada
Reiterated Rating
5/5/2021Rayonier Advanced MaterialsRoyal Bank of Canada
Downgrade
5/4/2021American VanguardRoth Capital
Boost Price Target
5/4/2021American VanguardLoop Capital
Boost Price Target
4/20/2021Wallbridge MiningEight Capital
Lower Price Target
4/15/2021Nomad RoyaltyRaymond James
Reiterated Rating
4/14/2021Nomad RoyaltyCIBC
Initiated Coverage
4/6/2021Nomad RoyaltyRaymond James
Lower Price Target
11/16/2020ZomedicaHC Wainwright
Lower Price Target
10/20/2020Rayonier Advanced MaterialsRoyal Bank of Canada
Upgrade
10/14/2020Wallbridge MiningEight Capital
Boost Price Target
8/20/2020Rayonier Advanced MaterialsRoyal Bank of Canada
Reiterated Rating
8/12/2020ZomedicaHC Wainwright
Reiterated Rating
7/13/2020Rayonier Advanced MaterialsRoyal Bank of Canada
Reiterated Rating
6/19/2020Rayonier Advanced MaterialsBank of America
Upgrade
6/17/2020ZomedicaHC Wainwright
Reiterated Rating
6/5/2020Rayonier Advanced MaterialsRoyal Bank of Canada
Downgrade
5/21/2020Wallbridge MiningEight Capital
Boost Price Target
5/7/2020Rayonier Advanced MaterialsRoyal Bank of Canada
Reiterated Rating
4/21/2020Wallbridge MiningEight Capital
Boost Price Target
2/27/2020Rayonier Advanced MaterialsDA Davidson
Reiterated Rating
10/22/2019American VanguardLoop Capital
Lower Price Target
10/16/2019Rayonier Advanced MaterialsBerenberg Bank
Downgrade
8/9/2019Rayonier Advanced MaterialsRoyal Bank of Canada
Set Price Target
8/8/2019Rayonier Advanced MaterialsSidoti
Downgrade
8/8/2019Rayonier Advanced MaterialsBank of America
Downgrade
6/5/2019ZomedicaHC Wainwright
Reiterated Rating
5/10/2019Rayonier Advanced MaterialsDA Davidson
Lower Price Target
(Data available from 12/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.